Clinical trials
Phase 2 Lymphoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 3 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2011 | 6 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Active, not recruiting | 5 |
| Unknown status | 5 |
| Terminated | 4 |
| Recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 5 |
| University College, London | 5 |
| Incyte Corporation | 4 |
| University of Birmingham | 4 |
| Cancer Research UK | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| ADC Therapeutics S.A. | 2 |
| AstraZeneca | 2 |
| Janssen Research & Development, LLC | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 56 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Follicular | 9 |
| Lymphoma, Mantle-Cell | 7 |
| Recurrence | 7 |
| Lymphoma, T-Cell, Cutaneous | 6 |
| Hodgkin Disease | 5 |
| Leukemia | 5 |
| Mycosis Fungoides | 5 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.